THERAPEUTIC POTENTIAL OF CHOLECYSTOKININ RECEPTOR ANTAGONISTS IN CNS DISORDERS

被引:10
|
作者
SCHIANTARELLI, P
机构
[1] Preclinical Research Division, Boehringer Ingelheim Italy, 20139 Milano
关键词
D O I
10.1006/phrs.1993.1104
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [31] Pharmacology of Metabotropic Glutamate Receptor Allosteric Modulators: Structural Basis and Therapeutic Potential for CNS Disorders
    Gregory, Karen J.
    Noetzel, Meredith J.
    Niswender, Colleen M.
    OLIGOMERIZATION AND ALLOSTERIC MODULATION IN G-PROTEIN COUPLED RECEPTORS, 2013, 115 : 61 - 121
  • [32] Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an in silico approach
    Garisetti, Vasavi
    Dhanabalan, Anantha Krishnan
    Dasararaju, Gayathri
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, : 4745 - 4758
  • [33] Therapeutic potential of GABAB receptor ligands in drug addiction, anxiety, depression and other CNS disorders
    Kumar, Kushal
    Sharma, Sorabh
    Kumar, Puneet
    Deshmukh, Rahul
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 110 : 174 - 184
  • [34] CHOLECYSTOKININ-DOPAMINE RECEPTOR INTERACTIONS AS STUDIED WITH CHOLECYSTOKININ RECEPTOR ANTAGONISTS
    MURPHY, RB
    DRUG DEVELOPMENT RESEARCH, 1984, 4 (04) : 457 - 457
  • [35] Therapeutic Potential of 5-HT2C Receptor Antagonists in the Treatment of Anxiety Disorders
    Wood, Martyn D.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (06) : 383 - 387
  • [36] THE THERAPEUTIC POTENTIAL OF CHOLECYSTOKININ
    SMITH, GP
    INTERNATIONAL JOURNAL OF OBESITY, 1984, 8 : 35 - 38
  • [37] Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders
    Xu, Heng
    Lu, Hongfu
    Xu, Zhongmiao
    Luan, Linbo
    Li, Chengyong
    Xu, Yan
    Dong, Kelly
    Zhang, Jinqiang
    Li, Xiong
    Li, Yvonne
    Liu, Gentao
    Gong, Sophie
    Zhao, Yong-Gang
    Liu, Ailian
    Zhang, Yueting
    Zhang, Wei
    Cai, Xin
    Xiang, Jia-Ning
    Elliott, John D.
    Lin, Xichen
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (04): : 397 - 402
  • [38] Synthetic studies on cholecystokinin receptor antagonists
    Satoh, Y
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2000, 58 (08) : 766 - 775
  • [39] CHARACTERIZATION OF CHOLECYSTOKININ(A) RECEPTOR AGONIST ACTIVITY BY A FAMILY OF CHOLECYSTOKININ(B) RECEPTOR ANTAGONISTS
    BLEVINS, GT
    VANDEWESTERLO, EMA
    YULE, DI
    WILLIAMS, JA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (03): : 911 - 916
  • [40] Dopamine receptor antagonists as potential therapeutic agents for ADPKD
    Paul, Parama
    Ramachandran, Sreekumar
    Xia, Sheng
    Unruh, Jay R.
    Conkright-Fincham, Juliana
    Li, Rong
    PLOS ONE, 2019, 14 (05):